Recro Pharma Inc (REPH) - Financial and Strategic SWOT Analysis Review

  • ID: 4278716
  • SWOT Analysis
  • 25 pages
  • GlobalData
1 of 5


  • Elite Pharmaceuticals Inc
  • Trevena Inc
  • Zogenix Inc
  • MORE

Recro Pharma Inc (Recro Pharma) is a specialty pharmaceutical company that develops non-opioid therapeutics for the treatment of pain. The company’s product candidates include dexmedetomidine, meloxicam and fadolmidine. Its dexmedetomidine is used in the treatment of chronic pain and cancer breakthrough pain. Recro Pharma’s fadolmidine is used for treating post-operative pain and neuropathic pain. It offers phase II clinical trial to demonstate the intrathecal fado and bupivacaine to cure bunionectomy patients. The company’s meloxicam is a NSAID with preferential COX-2 inhibition and used for treatment of symptoms of osteoarthritis and rheumatoid arthritis. It markets its products through its sales offices. Recro Pharma is headquartered in Malvern, Pennsylvania, the US.

Recro Pharma Inc Key Recent Developments

Mar 02, 2018: Recro Pharma Announces Commercial Team Additions
Feb 27, 2018: Recro Pharma Announces Year End 2017 Financial Results
Feb 02, 2018: Recro Pharma Announces Key Sales Team Additions
Nov 20, 2017: Recro Pharma Secures $100M Credit Facility
Nov 09, 2017: Recro Pharma Reports Third Quarter 2017 Financial Results

This comprehensive SWOT profile of Recro Pharma Inc provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of the author’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, the author’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Recro Pharma Inc including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including:
  • Business description - A detailed description of the company’s operations and business divisions.
  • Corporate strategy - Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives’ employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities - A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
*Note: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Product cover images may vary from those shown
2 of 5


  • Elite Pharmaceuticals Inc
  • Trevena Inc
  • Zogenix Inc
  • MORE
Section 1 - About the Company
  • Recro Pharma Inc - Key Information
  • Recro Pharma Inc - Overview
  • Recro Pharma Inc - Key Employees
  • Recro Pharma Inc - Key Employee Biographies
  • Recro Pharma Inc - Key Operational Heads
  • Recro Pharma Inc - Major Products and Services
  • Recro Pharma Inc - History
  • Recro Pharma Inc - Company Statement
  • Recro Pharma Inc - Locations And Subsidiaries
  • Recro Pharma Inc - Key Manufacturing facilities
  • Head Office
  • Other Locations & Subsidiaries
Section 2 - Company Analysis
  • Recro Pharma Inc - Business Description
  • Recro Pharma Inc - Corporate Strategy
  • Recro Pharma Inc - SWOT Analysis
  • SWOT Analysis - Overview
  • Recro Pharma Inc - Strengths
  • Recro Pharma Inc - Weaknesses
  • Recro Pharma Inc - Opportunities
  • Recro Pharma Inc - Threats
  • Recro Pharma Inc - Key Competitors
Section 3 - Company Financial Performance Charts
  • Recro Pharma Inc - Financial Ratios
  • Financial Ratios - Capital Market Ratios
  • Financial Ratios - Annual Ratios
  • Financial Ratios - Interim Ratios
  • Financial Ratios - Ratio Charts
Section 4 - Appendix
  • Appendix
  • Methodology
  • Ratio Definitions
  • About
  • Contact
  • Disclaimer
*Note: Some sections may be missing if data is unavailable for the company

List of Tables
  • Recro Pharma Inc, Key Information
  • Recro Pharma Inc, Key Ratios
  • Recro Pharma Inc, Share Data
  • Recro Pharma Inc, Major Products and Services
  • Recro Pharma Inc, History
  • Recro Pharma Inc, Key Employees
  • Recro Pharma Inc, Key Employee Biographies
  • Recro Pharma Inc, Key Operational Heads
  • Recro Pharma Inc, Other Locations
  • Recro Pharma Inc, Subsidiaries
  • Recro Pharma Inc, Key Manufacturing facilities
  • Recro Pharma Inc, Key Competitors
  • Recro Pharma Inc, SWOT Analysis
  • Recro Pharma Inc, Ratios based on current share price
  • Recro Pharma Inc, Annual Ratios
  • Recro Pharma Inc, Interim Ratios
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios
List of Figures
  • Recro Pharma Inc, Performance Chart
  • Recro Pharma Inc, Ratio Charts
Note: Product cover images may vary from those shown
3 of 5


4 of 5
  • Zogenix Inc
  • Trevena Inc
  • Elite Pharmaceuticals Inc
Note: Product cover images may vary from those shown
5 of 5
Note: Product cover images may vary from those shown